Results 131 to 140 of about 25,829 (192)
Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra‐High Risk for Psychosis
Early Intervention in Psychiatry, Volume 20, Issue 7, July 2026.ABSTRACT Aims
Negative symptoms are a core component of schizophrenia, affecting up to 60% of individuals with the disorder. They are categorised into primary negative symptoms (PNS), which are intrinsic to the illness, and secondary negative symptoms, which arise from external factors such as depression or medication side effects.Dulari Hakamuwa Lekamlage, Ling Min Amelia Ang, Luba Sominsky, Stephen J. Wood, Patrick D. McGorry, Cristina Mei, G. Paul Amminger, Hok Pan Yuen, Melissa Kerr, Jessica Spark, Nick Wallis, Andrea Polari, Shelley Baird, Kate Buccilli, Sarah‐Jane A. Dempsey, Natalie Ferguson, Melanie Formica, Marija Krcmar, Amelia L. Quinn, Yohannes Mebrahtu, Arlan Ruslins, Rebekah Street, Cassandra Wannan, Lisa Dixon, Cameron S. Carter, Rachel Loewy, Tara A. Niendam, Martha Shumway, Barnarby Nelson, David Cotter, Subash Susai, Alison R. Yung +31 morewiley +1 more sourceDirect Thrombectomy vs. Combined Treatment With Intravenous Thrombolysis in the Extended Time Window: A Target Trial Emulation
European Journal of Neurology, Volume 33, Issue 7, July 2026.This target‐trial emulation compared direct MT (n = 212) vs. IVT + MT (n = 135) in anterior‐circulation LVO patients treated 4.5–24 h or at wake‐up, eligible for IVT with perfusion mismatch. Using IPW with a non‐inferiority margin RD ≥ −1.3% for 90‐day mRS 0–2, direct MT was not non‐inferior to IVT + MT (adjRD −2.9%, 95% CI −6.64 to 0.84).Ettore Nicolini, Antonio Ciacciarelli, Giovanni Pracucci, Valentina Saia, Luigi Simonetti, Andrea Zini, Valerio Da Ros, Federica D'agostino, Marta Iacobucci, Manuela De Michele, Marco Andrighetti, Rossana Tassi, Andra Saletti, Ilaria Casetta, Enrico Fainardi, Alfredo Pauciulo, Marcella Caggiula, Roberto Menozzi, Alessandro Pezzini, Stefano Vallone, Guido Bigliardi, Domenico Sergio Zimatore, Marco Petruzzellis, Alessio Comai, Enrica Franchini, Luca Allegretti, Tiziana Tassinari, Nicola Limbucci, Patrizia Nencini, Giuseppe Carità, Monia Russo, Marco Filizzolo, Marina Mannino, Maria Ruggiero, Marco Longoni, Andrea Boghi, Andrea Naldi, Mauro Bergui, Giovanni Bosco, Giuseppe Pelle, Michele Alessiani, Matteo Alberti, Paolo Invernizzi, Raffaele Augelli, Manuel Cappellari, Guido Andrea Lazzarotti, Nicola Giannini, Daniel Konda, Fabrizio Sallustio, Salvatore Mangiafico, Danilo Toni, on behalf of the IRETAS group +51 morewiley +1 more sourceMultidisciplinary Evaluation of a 10‐Year Restoration Program for Two Endangered Atlantic Salmon (Salmo salar) Populations
Evolutionary Applications, Volume 19, Issue 7, July 2026.ABSTRACT
Supportive breeding programs are widely implemented to counteract demographic collapse in threatened populations. Their long‐term success, however, depends on maintaining genetic diversity while ensuring that released individuals contribute effectively to wild populations.Louarn Fauchet, Anne‐Laure Ferchaud, Jean‐Christophe Guay, Jean‐Sébastien Moore, Nicolas Derôme, Julien April, Louis Bernatchez +6 morewiley +1 more sourceExpert Clinical Consensus on Body Surface Gastric Mapping Phenotypes for Gastroduodenal Disorders: ‘Auckland Classification’ v1.0
Neurogastroenterology &Motility, Volume 38, Issue 7, July 2026.The Auckland Classification, derived by international consensus, presents a structured framework for BSGM‐defined patient phenotypes. This classification forms a foundation for research, further validation, and a pathway for integrating BSGM into clinical care. ABSTRACT Introduction
Chronic gastroduodenal disorders remain challenging to manage, and new Chris Varghese, Nicky Dachs, Gabriel Schamberg, Thomas Abell, Mohammad Al‐Haddad, Timothy Robert Angeli‐Gordon, Shahin Ayazi, Homira Ayubi, Mohammad Bashashati, Robert Bulat, Stefan Calder, Christopher Brian Cederwall, Bianca Chang, Leo Cheng, John Clarke, Charlotte Daker, Peng Du, Jon Erickson, Sven Eriksson, Asma Fikree, Daphne Foong, Mark Fox, Uday Chand Ghoshal, Mahesh Goenka, Rehan Haidry, William L. Hasler, Bu'Hussain Hayee, Vincent Ho, Gerald Holtman, Anthony Robert Hobson, I‐Hsuan Huang, Daniel Keszthelyi, Sahib S. Khalsa, Natasha Koloski, Braden Kuo, David Kunkel, Mikaela Law, David Levinthal, Joy J. Liu, Prateek Mathur, Baharak Moshiree, Leila Neshatian, Catherine Ngo, Linda Nguyen, Nicholas R. Oblizajek, Henry P. Parkman, Sanjay Pandanaboyana, Alexander Podboy, Ali Rezaie, Amol Sharma, Sam Simmonds, Jonathan Sivakumar, Jarongkorn Sirimongkolkasem, Irene Sonu, Abigail Stocker, Joseph Sujka, Jan Tack, Charles Verdonk, Xiao Jing Wang, Douglas Weinstein, John Windsor, Nicha Wongjarupong, William Xu, Natalia Zarate‐Lopez, Christopher N. Andrews, Armen A. Gharibans, Greg O'Grady +66 morewiley +1 more sourceMeeting Report From the 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Amsterdam, the Netherlands, October 2025
Pigment Cell &Melanoma Research, Volume 39, Issue 4, July 2026.ABSTRACT
The 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting took place in Amsterdam, The Netherlands on October 25th, 2025. Several promising drug candidates are in development; however, there is still an urgent need for better prevention, detection, and treatment of uveal melanoma.Andrew E. Aplin, Katherina Alsina, Allison S. Betof, Joseph Birkett, Marcus O. Butler, George Cole Jr., Rizwan Haq, Florian A. Karreth, Vinit B. Mahajan, Rahul Marpadga, Prithvi Mruthyunjaya, Paul Nathan, Jonas A. Nilsson, Gary Palmer, Joseph J. Sacco, Takami Sato, Sarah Stanhope, Pang‐ning Teng, Kyleigh LiPira +18 morewiley +1 more source
